Literature DB >> 29576888

Long Non-coding RNA in Liver Metabolism and Disease: Current Status.

Yulan Zhao1, Jianguo Wu1, Suthat Liangpunsakul2,3,4, Li Wang1,5,6,7.   

Abstract

Long non-coding RNAs (lncRNAs) are comprised of RNA transcripts exceeding 200 nucleotides in length but lacking identifiable open reading frames (with rare exceptions). Herein, we highlight emerging evidence demonstrating that lncRNAs are critical regulators of liver metabolic function and diseases. We summarize current knowledges about dysregulated lncRNAs and outline the underlying molecular mechanisms by which lncRNAs control hepatic lipid ad glucose metabolism, as well as cholestatic liver disease. lncLSTR, Lnc18q22.2, SRA, HULC, MALAT1, lncLGR, MEG3, and H19, lncHR1, lnc-HC, APOA1-AS, DYNLRB2-2, and LeXis are included in the discussion.

Entities:  

Keywords:  Long non-coding RNA; cholestatic liver disease; glucose metabolism; lipid metabolism; liver

Year:  2017        PMID: 29576888      PMCID: PMC5863923          DOI: 10.1016/j.livres.2017.09.001

Source DB:  PubMed          Journal:  Liver Res


  49 in total

1.  Downregulation of Long Noncoding RNA Meg3 Affects Insulin Synthesis and Secretion in Mouse Pancreatic Beta Cells.

Authors:  LiangHui You; Ning Wang; DanDan Yin; LinTao Wang; FeiYan Jin; YaNan Zhu; QingXin Yuan; Wei De
Journal:  J Cell Physiol       Date:  2015-09-09       Impact factor: 6.384

2.  H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.

Authors:  Yongfeng Song; Chune Liu; Xia Liu; Jocelyn Trottier; Michele Beaudoin; Li Zhang; Chad Pope; Guangyong Peng; Olivier Barbier; Xiaobo Zhong; Linheng Li; Li Wang
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

Review 3.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

4.  HBx-related long non-coding RNA MALAT1 promotes cell metastasis via up-regulating LTBP3 in hepatocellular carcinoma.

Authors:  Zhouhua Hou; Xuwen Xu; Xiaoyu Fu; Shuhui Tao; Jiebin Zhou; Shuiping Liu; Deming Tan
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

5.  Small heterodimer partner/neuronal PAS domain protein 2 axis regulates the oscillation of liver lipid metabolism.

Authors:  Sang Min Lee; Yuxia Zhang; Hiroyuki Tsuchiya; Rana Smalling; Anton M Jetten; Li Wang
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

6.  Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.

Authors:  Yang-Hua Fan; Miao-Jing Wu; Yuan Jiang; Minhua Ye; Shi-Gang Lu; Lei Wu; Xin-Gen Zhu
Journal:  Oncotarget       Date:  2017-03-28

7.  SRA regulates adipogenesis by modulating p38/JNK phosphorylation and stimulating insulin receptor gene expression and downstream signaling.

Authors:  Shannon Liu; Ruichuan Xu; Isabelle Gerin; William P Cawthorn; Ormond A Macdougald; Xiao-Wei Chen; Alan R Saltiel; Ronald J Koenig; Bin Xu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

Review 8.  On the classification of long non-coding RNAs.

Authors:  Lina Ma; Vladimir B Bajic; Zhang Zhang
Journal:  RNA Biol       Date:  2013-04-15       Impact factor: 4.652

9.  LncRNA SRA promotes hepatic steatosis through repressing the expression of adipose triglyceride lipase (ATGL).

Authors:  Gang Chen; Dongsheng Yu; Xue Nian; Junyi Liu; Ronald J Koenig; Bin Xu; Liang Sheng
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

10.  High-mobility-group protein 2 regulated by microRNA-127 and small heterodimer partner modulates pluripotency of mouse embryonic stem cells and liver tumor initiating cells.

Authors:  Yulan Zhao; Zhihong Yang; Jianguo Wu; Raymond Wu; Santosh K Keshipeddy; Dennis Wright; Li Wang
Journal:  Hepatol Commun       Date:  2017-08-28
View more
  16 in total

Review 1.  Regulatory Non-Coding RNAs in Familial Hypercholesterolemia, Theranostic Applications.

Authors:  Hani Keshavarz Alikhani; Mahsa Pourhamzeh; Homeyra Seydi; Bahare Shokoohian; Nikoo Hossein-Khannazer; Fatemeh Jamshidi-Adegani; Sulaiman Al-Hashmi; Moustapha Hassan; Massoud Vosough
Journal:  Front Cell Dev Biol       Date:  2022-06-23

Review 2.  Long noncoding RNAs-a new dimension in the molecular architecture of the bile acid/FXR pathway.

Authors:  Yonghe Ma; Jamie Harris; Ping Li; Haiming Cao
Journal:  Mol Cell Endocrinol       Date:  2021-02-01       Impact factor: 4.102

Review 3.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

4.  Targeting Human lncRNAs for Treating Cardiometabolic Diseases.

Authors:  Xiangbo Ruan
Journal:  Cardiovasc Drugs Ther       Date:  2021-02-20       Impact factor: 3.947

Review 5.  The long and the small collide: LncRNAs and small heterodimer partner (SHP) in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Li Wang
Journal:  Mol Cell Endocrinol       Date:  2021-03-26       Impact factor: 4.369

Review 6.  Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases.

Authors:  Zhihong Yang; Ting Zhang; Sen Han; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul
Journal:  Transl Res       Date:  2020-11-20       Impact factor: 10.171

7.  Co-expression network analysis of lncRNAs and mRNAs in rat liver tissue reveals the complex interactions in response to pathogenic cytotoxicity.

Authors:  Dongliang Leng; Chen Huang; Kuan Cheok Lei; Shixue Sun; Baoqing Sun; Xiaohua Douglas Zhang
Journal:  Int J Biol Sci       Date:  2019-08-22       Impact factor: 6.580

8.  Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.

Authors:  Stefania Di Mauro; Alessandra Scamporrino; Salvatore Petta; Francesca Urbano; Agnese Filippello; Marco Ragusa; Maria T Di Martino; Francesca Scionti; Stefania Grimaudo; Rosaria M Pipitone; Graziella Privitera; Antonino Di Pino; Roberto Scicali; Luca Valenti; Paola Dongiovanni; Anna Fracanzani; Agata M Rabuazzo; Antonio Craxì; Michele Purrello; Francesco Purrello; Salvatore Piro
Journal:  Liver Int       Date:  2019-06-26       Impact factor: 5.828

Review 9.  Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis.

Authors:  Wen-Chu Ye; Shi-Feng Huang; Lian-Jie Hou; Hai-Jiao Long; Kai Yin; Ching Yuan Hu; Guo-Jun Zhao
Journal:  Front Cardiovasc Med       Date:  2021-06-10

Review 10.  Long noncoding RNAs in lipid metabolism: literature review and conservation analysis across species.

Authors:  Kevin Muret; Colette Désert; Laetitia Lagoutte; Morgane Boutin; Florence Gondret; Tatiana Zerjal; Sandrine Lagarrigue
Journal:  BMC Genomics       Date:  2019-11-21       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.